Canada · Health Canada Drug Product Database

TWINRIX

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
49687
DIN
02230578
Form
Suspension
Company as listed by source
GLAXOSMITHKLINE INC
Source status
Marketed (2002-11-06)
Source last updated
2025-07-30

Source-listed ingredients

  • HEPATITIS A VIRUS, INACTIVATED — 720 UNIT — per 1 ML
  • HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) — 20 MCG — per 1 ML

These values do not establish equivalence or a dose recommendation.

Packages

  • 10x1ml

Source and coverage

Open Health Canada Drug Product Database

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →